Press Releases Emmaus Life Sciences, Inc.

Equities

EMMA

US29137T1016

Market Closed - OTC Markets Other stock markets 17:53:55 26/04/2024 BST			5-day change	1st Jan Change
0.1 ^USD	0.00%		+8.58%	-0.10%

02-02	Emmaus Life Sciences, Inc. Receives Marketing Authorization from the Puerto Rico Department of Health for Endari® (L-Glutamine Oral Powder)	CI
2023	Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Emmaus Life Sciences Reports Delayed Filing of Annual Report	04-15	PR
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico	02-02	PR
Emmaus Life Sciences : Material Agreement - Form 8-K	12-20	PU
Emmaus Life Sciences Reports Q3 2023 Financial Results	11-14	PR
Emmaus Life Sciences Reports Management Changes	23/08/23	PR
Emmaus Life Sciences Reports Q2 2023 Financial Results	14/08/23	PR
Emmaus Life Sciences : Reports Q2 2023 Financial Results - Form 8-K	14/08/23	PU
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman	13/07/23	PR
Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA	31/05/23	PR
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update	15/05/23	PR
Emmaus Life Sciences Provides Interim Shipment Data	03/04/23	PR
Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update	31/03/23	PR
EMMAUS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/23	AQ
Emmaus Life Sciences : Private Placement - Form 8-K	07/03/23	PU
EMMAUS LIFE SCIENCES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07/03/23	AQ
Emmaus Life Sciences : Private Placement - Form 8-K	19/01/23	PU
EMMAUS LIFE SCIENCES, INC. : Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/01/23	AQ
Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®	19/12/22	PR
Emmaus Life Sciences : Submission of Matters to a Vote of Security Holders - Form 8-K	12/12/22	PU
EMMAUS LIFE SCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	12/12/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Emmaus Life Sciences, Inc.

Equities

EMMA

US29137T1016

Press Releases

Filters